Q32 Bio Inc. (QTTB) Payables (2017 - 2026)

Q32 Bio has reported Payables for 10 years, with the latest figure at $1.6 million in Q2 2026.

• On a quarterly basis, Payables rose 71.98% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $1.6 million, a 71.98% increase from a year earlier, with the FY2025 full-year figure at $879000.0, down 70.59% from the prior year.
• Payables was $1.6 million for Q2 2026 at Q32 Bio, up from $653000.0 in the prior quarter.
• The five-year high for Payables was $9.9 million in Q1 2022, with the low at $653000.0 in Q1 2026.
• Average Payables over 5 years is $3.2 million, with a median of $2.9 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Payables soared 203.15% in 2023, then plunged 83.88% in 2024.
• Over 5 years, Payables stood at $1.1 million in 2022, then jumped by 203.15% to $3.5 million in 2023, then dropped by 13.81% to $3.0 million in 2024, then plunged by 70.59% to $879000.0 in 2025, then soared by 78.04% to $1.6 million in 2026.
• The last three Payables figures came in at $1.6 million (Q2 2026), $653000.0 (Q1 2026), and $879000.0 (Q4 2025), per Business Quant data.